# Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity

> **NCT07158177** · NA · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 40 (estimated)

## Conditions studied

- Cataract and IOL Surgery

## Interventions

- **DEVICE:** Acrysof™ PanOptix™ toric or not, trifocal IOL CE marked, Alcon company.
- **DEVICE:** Clareon Panoptix

## Key facts

- **NCT ID:** NCT07158177
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-10-15
- **Final completion:** 2026-10-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07158177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07158177, "Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07158177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*